2019 AHA科学声明:重症监护室中老年患者的管理—老年综合征

2019-12-09 美国心脏协会 Circulation. 2019 Dec 9.

近日,Circulation发表了美国心脏协会(AHA)关于心脏重症监护病房(CCU)对老年患者进行管理的一份科学声明。该声明向心脏病学家强调了老年患者在CCU中可能遇到的一些问题,并就患者的管理策略提出了一些建议。

中文标题:

2019 AHA科学声明:重症监护室中老年患者的管理—老年综合征

英文标题:

Older Adults in the Cardiac Intensive Care Unit: Factoring Geriatric Syndromes in the Management, Prognosis, and Process of Care: A Scientific Statement From the American Heart Association.

发布机构:

美国心脏协会

发布日期:

2019-12-09

简要介绍:

近日,Circulation发表了美国心脏协会(AHA)关于心脏重症监护病房(CCU)对老年患者进行管理的一份科学声明。该声明向心脏病学家强调了老年患者在CCU中可能遇到的一些问题,并就患者的管理策略提出了一些建议。

 

拓展指南:老年相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 AHA科学声明:重症监护室中老年患者的管理—老年综合征)] GetToolGuiderByIdResponse(projectId=1, id=bebc31c0018a3ea7, title=2019 AHA科学声明:重症监护室中老年患者的管理—老年综合征, enTitle=Older Adults in the Cardiac Intensive Care Unit: Factoring Geriatric Syndromes in the Management, Prognosis, and Process of Care: A Scientific Statement From the American Heart Association., guiderFrom=Circulation. 2019 Dec 9., authorId=null, author=, summary=近日,Circulation发表了美国心脏协会(AHA)关于心脏重症监护病房(CCU)对老年患者进行管理的一份科学声明。该声明向心脏病学家强调了老年患者在CCU中可能遇到的一些问题,并就患者的管理策略提出了一些建议。 , cover=, journalId=null, articlesId=null, associationId=60, associationName=美国心脏协会, associationIntro=美国心脏协会(AHA,American Heart Association)是心脏病学领域比较正要的学会之一,致力于心脏病和卒中的预防与治疗,提供相关继续教育、流行病学年度报告。每年举办学术年会报道中的的临床试验结果等,有官方杂志《美国心脏协会杂志》,提供心血管疾病和卒中相关的指南及专家共识,更新的比较快。, copyright=0, guiderPublishedTime=Mon Dec 09 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>近日,Circulation发表了美国心脏协会(AHA)关于心脏重症监护病房(CCU)对老年患者进行管理的一份科学声明。该声明向心脏病学家强调了老年患者在CCU中可能遇到的一些问题,并就患者的管理策略提出了一些建议。 </P> <P> </P>拓展指南:<strong>与<font color=red>老年</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=91cf21c0018363fb" title="感染诱发的老年多器官功能障碍综合征诊断与治疗中国指南2019" target=_blank>感染诱发的老年多器官功能障碍综合征诊断与治疗中国指南2019</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=662a31c001809308" title="《2019年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南》——老年人血脂管理解读" target=_blank>《2019年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南》——老年人血脂管理解读</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=a9e091c00180a220" title="《2019年欧洲心脏病学会慢性冠状动脉综合征诊断和管理指南》——老年慢性冠状动脉综合征管理解读" target=_blank>《2019年欧洲心脏病学会慢性冠状动脉综合征诊断和管理指南》——老年慢性冠状动脉综合征管理解读</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=566b31c0018019a9" title="老年人维生素D营养素强化补充规范共识" target=_blank>老年人维生素D营养素强化补充规范共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=27e1c1c001801e24" title="中国老年人便秘评估技术应用共识(草案)" target=_blank>中国老年人便秘评估技术应用共识(草案)</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E8%80%81%E5%B9%B4" target=_blank>有关老年更多指南</a></ul>, tagList=[TagDto(tagId=35207, tagName=重症监护室), TagDto(tagId=2561, tagName=老年患者), TagDto(tagId=90317, tagName=老年综合征)], categoryList=[CategoryDto(categoryId=19, categoryName=老年医学, tenant=100), CategoryDto(categoryId=38, categoryName=急重症科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5151, appHits=270, showAppHits=16, pcHits=2736, showPcHits=3448, likes=57, shares=10, comments=6, approvalStatus=1, publishedTime=Thu Dec 26 23:34:26 CST 2019, publishedTimeString=2019-12-09, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Dec 26 23:34:26 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 11:58:19 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 AHA科学声明:重症监护室中老年患者的管理—老年综合征)])
2019 AHA科学声明:重症监护室中老年患者的管理—老年综合征
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=944202, encodeId=be7794420259, content=好声明!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Feb 28 14:58:18 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918001, encodeId=326391800168, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=038b5126242, createdName=14647804m28暂无昵称, createdTime=Tue Jan 19 11:23:04 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902224, encodeId=53cd90222427, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9cb5438426, createdName=ms5000001559827487, createdTime=Wed Nov 25 16:56:25 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805492, encodeId=682b805492c5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5142645505, createdName=619103330, createdTime=Sat Aug 01 08:26:27 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804983, encodeId=b4028049831c, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5142645505, createdName=619103330, createdTime=Tue Jul 28 23:31:33 CST 2020, time=2020-07-28, status=1, ipAttribution=)]
    2021-02-28 jyzxjiangqin

    好声明!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=944202, encodeId=be7794420259, content=好声明!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Feb 28 14:58:18 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918001, encodeId=326391800168, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=038b5126242, createdName=14647804m28暂无昵称, createdTime=Tue Jan 19 11:23:04 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902224, encodeId=53cd90222427, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9cb5438426, createdName=ms5000001559827487, createdTime=Wed Nov 25 16:56:25 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805492, encodeId=682b805492c5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5142645505, createdName=619103330, createdTime=Sat Aug 01 08:26:27 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804983, encodeId=b4028049831c, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5142645505, createdName=619103330, createdTime=Tue Jul 28 23:31:33 CST 2020, time=2020-07-28, status=1, ipAttribution=)]
    2021-01-19 14647804m28暂无昵称

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=944202, encodeId=be7794420259, content=好声明!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Feb 28 14:58:18 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918001, encodeId=326391800168, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=038b5126242, createdName=14647804m28暂无昵称, createdTime=Tue Jan 19 11:23:04 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902224, encodeId=53cd90222427, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9cb5438426, createdName=ms5000001559827487, createdTime=Wed Nov 25 16:56:25 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805492, encodeId=682b805492c5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5142645505, createdName=619103330, createdTime=Sat Aug 01 08:26:27 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804983, encodeId=b4028049831c, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5142645505, createdName=619103330, createdTime=Tue Jul 28 23:31:33 CST 2020, time=2020-07-28, status=1, ipAttribution=)]
    2020-11-25 ms5000001559827487

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=944202, encodeId=be7794420259, content=好声明!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Feb 28 14:58:18 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918001, encodeId=326391800168, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=038b5126242, createdName=14647804m28暂无昵称, createdTime=Tue Jan 19 11:23:04 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902224, encodeId=53cd90222427, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9cb5438426, createdName=ms5000001559827487, createdTime=Wed Nov 25 16:56:25 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805492, encodeId=682b805492c5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5142645505, createdName=619103330, createdTime=Sat Aug 01 08:26:27 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804983, encodeId=b4028049831c, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5142645505, createdName=619103330, createdTime=Tue Jul 28 23:31:33 CST 2020, time=2020-07-28, status=1, ipAttribution=)]
    2020-08-01 619103330

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=944202, encodeId=be7794420259, content=好声明!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun Feb 28 14:58:18 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918001, encodeId=326391800168, content=学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=038b5126242, createdName=14647804m28暂无昵称, createdTime=Tue Jan 19 11:23:04 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902224, encodeId=53cd90222427, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9cb5438426, createdName=ms5000001559827487, createdTime=Wed Nov 25 16:56:25 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805492, encodeId=682b805492c5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5142645505, createdName=619103330, createdTime=Sat Aug 01 08:26:27 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804983, encodeId=b4028049831c, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5142645505, createdName=619103330, createdTime=Tue Jul 28 23:31:33 CST 2020, time=2020-07-28, status=1, ipAttribution=)]
    2020-07-28 619103330

    不错

    0